Newborn and Infant Nursing Reviews
Volume 6, Issue 3 , Pages e1-e8 , September 2006

Hydrops Fetalis

  • Leslie A. Parker, RNC, MSN, NNP

      Affiliations

    • Corresponding Author InformationAddress correspondences to Leslie A. Parker, RNC, MSN, NNP, College of Nursing, University of Florida, Box 100186 CON UF, Gainesville, FL 32610.

References 

  1. Bukowski R, Saade GR. Hydrops fetalis. Clin Perinatol. 2000;27:1007–1031
  2. Jones DC. Nonimmune fetal hydrops: diagnosis and obstetrical management. Semin Perinatol. 1995;19:447–461
  3. Heinonen S, Ryynanen M, Kirkinen P, et al. Etiology and outcome of second trimester non-immunologic fetal hydrops. Acta Obstet Gynecol Scand. 2000;79:15–18
  4. Machim GA. Hydrops revisited: literature review of 1414 cases published in the 1980s. Am J Med Genet. 1989;34:366–390
  5. Henrich W, Heeger J, Schmider A, et al. Complete spontaneous resolution of severe nonimmunological hydrops with unknown etiology in the second trimester—a case report. J Perinat Med. 2002;30:522–527
  6. Moise K. Management of rhesus alloimmunization in pregnancy. Obstet Gynecol. 2002;100:600–611
  7. Chen M, Chen CP, Shih JC, et al. Antenatal treatment of chylothorax and cystic hygroma with OK-432 in nonimmune hydrops fetalis. Fetal Diagn Ther. 2005;20:309–315
  8. Rose CH, Bofill JA, Le M, et al. Non-immune hydrops fetalis: prenatal diagnosis and perinatal outcomes. J Miss State Med Assoc. 2005;46:99–102
  9. Maayan-Metzger A, Sack J, Mazkereth R, et al. Somatostatin treatment of congenital chylothorax may induce transient hypothyroidism in newborns. J Korean Med Scio. 2005;94:785–789
  10. De Groot CJM, Oepkes D, Egberts J, et al. Evidence of endothelium involvement in the pathophysiology of hydrops fetalis?. Early Hum Dev. 2000;57:205–209
  11. Sohan K, Carroll SG, De la Fuente S, et al. Analysis of outcome in hydrops fetalis in relation to gestational age at diagnosis, cause and treatment. Acta Obstet Gynecol Scand. 2001;80:726–730
  12. Santolaya J, Alley D, Jaffe R, et al. Antenatal classification of hydrops fetalis. Obstet Gynecol. 1992;79:256–259
  13. Ziprin JH, Payne E, Hamidi L, et al. ABO incompatibility due to immunoglobulin G anti-B antibodies presenting with severe fetal anaemia. Transfus Med. 2005;15:57–60
  14. Kollamparambil TG, Jani BR, Aldouri M, et al. Acti-Cw alloimmunization presenting as hydrops fetalis. Acta Paediatr. 2005;94:499–501
  15. Joy SD, Rossi KQ, Krugh D, et al. Management of pregnancies complicated by anti-E alloimmunization. Obstet Gynecol. 2005;105:24–28
  16. Wu KH, Chu SL, Chang JG, et al. Haemolytic disease of the newborn due to maternal irregular antibodies in the Chinese population of Taiwan. Transfus Med. 2003;13:311–314
  17. Queenan JT, Tomai TP, Ural SH, et al. Deviation in amniotic fluid optical density at a wavelength of 450 nm in Rh-immunized pregnancies from 14 to 40 weeks' gestation: a proposal for clinical management. Am J Obstet Gynecol. 1993;168:1370–1376
  18. Neppert J, vWitzleben-Schuholz E, Zupanska G, et al. High incidence of maternal HLA A, B and C antibodies associated with a mild course of haemolytic disease of the newborn. Group for the Study of Protective Maternal HLA Antibodies in the Clinical Course of HDN. Eur J Haematol. 1999;173:747–753
  19. Moise KJ, Schumacher B, Anemia N. In:  Fisk M,  Moise KJ editor. Fetal therapy invasive and transplacental. Cambridge, UF: Cambridge University Press; 1997;p. 141–163
  20. Maeno Y, Himeno W, Saito A. Clinical course of fetal congenital atrioventricular block in the Japanese population: a multicentre population. Heart. 2005;91:1075–1079
  21. Allan LD, Sharland GK, Milburn A, et al. Prospective diagnosis of 1,006 consecutive cases of congenital heart disease in the fetus. J Am Coll Cardiol. 1994;23:1452–1458
  22. Tongsong T, Chanprapaph P, Khunamornpong S, et al. Sonographic features of Ebstein anomaly associated with hydrops fetalis: a report of two cases. J Clin Ultrasound. 2005;33:149–153
  23. Kleinman CS, Nehgme RA. Cardiac arrhythmias in the human fetus. Pediatr Cardiol. 2004;25:234–251
  24. Allan LD, Crawford DC, Sheridan R, et al. Aetiology of non-immune hydrops: the value of echocardiography. Br J Obstet Gynaecol. 1986;93:223–235
  25. Berg C, Geipel A, Kohl T, et al. Atrioventricular block detected in fetal life: associated anomalies and potential prognostic markers. Ultrasound Obstet Gynecol. 2005;26:4–15
  26. Swain S, Cameron AD, McNay MB, et al. Prenatal diagnosis and management of nonimmune hydrops fetalis. Aust N Z J Obstet Gynaecol. 1999;39:285–290
  27. Duwanrath-Kengpol C, Limprasert P, Mitarnun W. Prenatal diagnosis of deletion of chromosome 6p presenting with fetal hydrops. Prenat Diagn. 2004;24:887–889
  28. Leonard JV, Morris AA. Diagnosis and early management of inborn errors of metabolism presenting around the time of birth. Acta Paediatr. 2006;95:6–14
  29. Eblan MJ, Goker-Alpan O, Sidransky E. Perinatal lethal Gaucher disease: a distinct phenotype along the neuronopathic continuum. Fetal Pediat Pathol. 2005;24:205–222
  30. Wong S, Brown KE. Development of an improved method of detection of infectious Parvovirus B19. J Clin Virol. 2006;35:407–413
  31. Rodriguez MM, Chaves F, Romaguera RL, et al. Value of autopsy in nonimmune hydrops fetalis: series of 51 stillborn fetuses. Pediatr Dev Pathol. 2002;5:365–374
  32. Sampath V, Narendran V, Donovan EF, et al. Nonimmune hydrops fetalis and fulminant fatal disease due to congenital cytomegalovirus infection in a premature infant. J Perinatol. 2005;25:608–611
  33. Barron SD, Pass RF. Infectious causes of hydrops fetalis. Semin Perinatol. 1995;19:493–501
  34. Brown KE. Haematological consequences of Parvovirus B19 infection. Baillieres Best Pract Res Clin Haematol. 2000;13:245–259
  35. Hartung J, Chaoui R, Bollmann R. Nonimmune hydrops from fetomaternal hemorrhage treated with serial fetal intravascular transfusion. Obstet Gynecol. 2000;96:844–845
  36. Lorry F, Charoenkwan P, Witkowska HE, et al. Hb H hydrops foetalis syndrome: a case report and review of literature. Br J Haematol. 2001;115:72–78
  37. Dunbar AE, Moore SL, Hinson RM. Fetal Diamond-Blackfan anemia associated with hydrops fetalis. Am J Perinatol. 2003;20:391–394
  38. Asabe K, Oka Y, Shirakusa T. Fetal case of congenital cystic adenomatoid malformation of the lung: fetal therapy and a review of the published reports in Japan. Congenit Anom. 2005;45:96–101
  39. Favre R, Dreux S, Dommergues M, et al. Nonimmune fetal ascites: a series of 79 cases. Am J Obstet Gynecol. 2004;190:407–412
  40. Yildiz K, Ozcan N, Cebi M, et al. Intrapericardial extralobar pulmonary sequestration: unusual cause of hydrops fetalis. J Ultrasound Med. 2005;24:391–393
  41. Ochial M, Hikino S, Nakayama H, et al. Nonimmune hydrops due to generalized lymphatic dysplasia in an infant with robertsonian trisomy 21. Am J Perinatol. 2006;23:63–66
  42. Rodeck CH, Risk NM, Fraser DL, et al. Long-term in utero drainage of fetal hydrothorax. N Engl J Med. 1988;319:1135–1138
  43. Suri V, Aggarwal N, Deo ND, et al. Placental chorioangioma with hydrops foetalis: a case report. Acta Obstet Gynecol Scand. 2005;84:603–604
  44. Nakata M, Fujuwara M, Ishikawa Y, et al. Prenatal diagnosis and management for a large fetal cardiac tumor complicated with hydrops fetalis. J Obstet Gynaecol. 2005;31:476–479
  45. Whitecar PW, Moise KJ. Sonographic methods to detect fetal anemia in red blood cell alloimmunization. Obstet Gynecol Surv. 2000;55:240–250
  46. Xu J, Raff TC, Muallem NS, et al. Hydrops fetalis secondary to Parvovirus B19 infections. J Am Board Fam Pract. 2003;16:63–68
  47. Dong ZW, Zhou SY, Li Y, et al. Detection of a human Parvovirus intrauterine infection with the polymerase chain reaction. J Reprod Med. 2000;45:410–412
  48. Maxwell DJ, Johnson P, Hurley P, et al. Fetal blood sampling and pregnancy loss in relation to indication. Br J Obstet Gynaecol. 1991;98:892–897
  49. Abdel-Fettah SA, Soothill PW, Carroll SG, et al. Noninvasive diagnosis of anemia in hydrops fetalis with the use of middle cerebral artery Doppler velocity. Am J Obstet Gynecol. 2001;185:1411–1415
  50. Ahmed B, Ghaffrari Z, Ismail RS, et al. Non-invasive diagnosis of fetal anemia due to maternal red-cell alloimmunization. Saudi Med J. 2005;26:256–259
  51. Strasburger JF, Cuneo BF, Michon MM, et al. Amiodarone therapy for drug-refractory fetal tachycardia. Circulation. 2004;10:375–379
  52. Jonannie JM, Delahaye S, Fermont L, et al. Fetal supraventricular tachycardia: a role for amiodarone as second-line therapy. Prenat Diagn. 2003;23:152–156
  53. Tanawattancharoen S, Uerpairojkit B, Prechawat S, et al. Intrauterine therapy for fetal supraventricular tachycardia in a twin pregnancy. J Obstet Gynaecol Res. 2005;31:94–97
  54. Porat S, Anteby EY, Hanani Y, et al. Fetal supraventricular tachycardia diagnosed and treated at 13 weeks of gestation: a case report. Ultrasound Obstet Gynecol. 2003;21:302–305
  55. Dimase VV, Taylor MC, Cunnyngham CB, et al. Transplacental pharmacokinetics of flecainide in the gravid baboon and fetus. Pediatr Cardiol. 2005;26:815–820
  56. Schmolling J, Renke K, Richter O, et al. Digoxin, flecainide and amiodarone transfer across the placenta and the effect of an elevated umbilical venous pressure on the transfer rate. Ther Drug Monit. 2000;22:582–588
  57. van Kamp IL, Klumper FJ, Oepkes D, et al. Complications of intravascular intrauterine transfusion for fetal anemia due to maternal red cell alloimmunization. Am J Obstet Gynecol. 2005;192:171–177
  58. Band J, Bock JE, Trolle D. Ultrasound-guided fetal intravenous transfusion for severe rhesus haemolytic disease. BMJ. 1982;284:373–374
  59. van Kamp IL, Frans MD, Klumper CJM, et al. The severity of immune fetal hydrops is predictive of fetal outcome after intrauterine treatment. Am J Obstet Gynecol. 2001;185:668–673
  60. Thibeault DW, Black P, Taboada E. Fetal hydrops and familial pulmonary lympathic hypoplasia. Am J Perinatol. 2002;19:323–331
  61. Daniel-Spiegel E, Ghalamkarpour A, Spiegel R, et al. Hydrops fetalis: an unusual prenatal presentation of hereditary congenital lymphedema. Prenat Diagn. 2005;25:1015–1018
  62. Walsh DS, Advick NS. Fetal surgical intervention. Am J Perinatol. 2000;17:277–283
  63. Smith RP, Illanes S, Denbow ML. Outcome of fetal pleural effusions treated by thoracoamniotic shunting. Ultrasound Obstet Gynecol. 2005;26:63–66
  64. Hamada H, Yasauka M, Urushigawa K, et al. Successful treatment of primary fetal hydrothorax with hydrops by pleuroamniotic shunt placement. Arch Gynecol Obstet. 2001;265:53–54
  65. Picone O, Benachi A, Mandelbrot L, et al. Thoracoamniotic shunting for fetal pleural effusions with hydrops. Am J Obstet Gynecol. 2004;191:2047–2050
  66. Graf JL, Albanese CT, Jenning RW, et al. Successful fetal sacrococcygeal teratoma resection in a hydroptic fetus. J Pediatr Surg. 2000;35:1489–1491
  67. Mesogitis S, Daskalakis G, Pilalis A, et al. Fetal intravascular transfusion for hydropic disease due to rhesus isoimmunization. Fetal Diagn Ther. 2005;20:431–436
  68. Wafelman LS, Pollock BH, Kreutzer J, et al. Nonimmune hydrops fetalis: fetal and neonatal outcome during 1983-1992. Biol Neonate. 1999;75:73–81
  69. Kleinman CS, Donnerstein RI, DeVore GR, et al. Fetal echocardiography for evaluation of in utero congestive heart failure. N Engl J Med. 1982;306:568–575

PII: S1527-3369(06)00067-5

doi: 10.1053/j.nainr.2006.05.006

Newborn and Infant Nursing Reviews
Volume 6, Issue 3 , Pages e1-e8 , September 2006

Article Tools

* Image Usage & Resolution